Valturna
Links shared publicly online about this topic
Valturna approved for treatment of hypertension - MPR
empr.com — “The FDA has approved Valturna (aliskiren and valsartan tablets, from Novartis), a combination agent containing a direct renin inhibitor and an angiotensin receptor blocker, for the treatment of high blood pressure in patients not adequately controlled on aliskiren or angiotensin receptor blocker (ARB) monotherapy and as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.” View full resource at empr.com
Most Recently Shared on September 18, 2009 at 3:42 pm By:
MPR News: Valturna approved for treatment of hypertension: The FDA has approved Valturna (aliskiren and.. http://bit.ly/QLS85
FDA approves Valturna tablets for treating high blood pressure
news-medical.net — “The US Food and Drug Administration (FDA) has approved Valturna((R)) (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS), an important regulator of blood pressure.” View full resource at news-medical.net
Most Recently Shared on September 18, 2009 at 7:07 pm By:
Stroke News: FDA approves Valturna tablets for treating high blood pressure: The US Food and Drug Ad.. http://twurl.nl/wox5n0
Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
drugs.com — “Valturna (aliskiren and valsartan) is used to treat high blood pressure. Includes Valturna side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 17, 2009 at 11:49 pm By:
FDA Approves Valturna (aliskiren and valsartan) to treat high blood pressure - http://bit.ly/2jfQfe
Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
novartis.com — “Basel, September 17, 2009 - The US Food and Drug Administration (FDA) has approved Valturna (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS), an important regulator of blood pressure[2]. This is the first approval for Valturna, which is indicated for the treatment of high blood pressure in patients not adequately controlled on aliskiren or angiotensin receptor blocker (AR” View full resource at novartis.com
Most Recently Shared on September 18, 2009 at 7:52 am By:
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren http://twurl.nl/samel4
FDA approves aliskiren/valsartan combo for hypertension
theheart.org — “TheHeart.org is the most trusted source for cardiology news, commentary and continuing medical education on the web.” View full resource at theheart.org
Most Recently Shared on September 22, 2009 at 7:45 pm By:
heartwire: FDA approves aliskiren/valsartan combo for HTN http://bit.ly/3wKirt
Medical News: FDA Approves Single-Pill Duo for Hypertension - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “The FDA approved a single-pill combination of the renin inhibitors valsartan and aliskiren (Valturna) for treatment of high blood pressure.” View full resource at medpagetoday.com
Most Recently Shared on September 18, 2009 at 2:48 pm By:
RT @health_tweets: FDA Approves Single-Pill Duo for Hypertension http://bit.ly/3onaEX
FDA Approves Aliskiren/Valsartan Combination Pill - Renal and Urology News
renalandurologynews.com — “FDA has approved Valturna (aliskiren and valsartan) tablets, which the drug's maker, Novartis, of East Hanover, N.J., said is the first and only product to target two key points in the renin angiotensin aldosterone system (RAAS).” View full resource at renalandurologynews.com
Most Recently Shared on October 16, 2009 at 6:37 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
FDA Approves Aliskiren/Valsartan Combination Pill: FDA has approved Valturna (aliskiren and valsartan) tablets, .. http://bit.ly/B0wSx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
News-Medical.Net
Stay up to date with the latest Stroke news and research via News-Medical.Net
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
